PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate treatment adherence to different regimens of
ibandronate in postmenopausal women with osteoporosis or osteopenia who are intolerant to
daily or weekly alendronate or risedronate therapy due to gastrointestinal (GI) side effects.
The anticipated time on study treatment is 12 months, and the target sample size is 517
individuals.